menu
    • menu

    Company profile for HLS Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a stron...
    HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HLS TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    10 Carlson Court, Suite 701 Etobicoke, Ontario, M9W 6L2
    Telephone
    Telephone
    1-647-495-9000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hlstherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HLS Therapeutics's Nilemdo Approved in Canada
    HLS Therapeutics's Nilemdo Approved in Canada

    14 Nov 2025

    // HEALTH CANADA

    https://pdf.hres.ca/dpd_pm/00082429.PDF

    HEALTH CANADA
    14 Nov 2025
    Share Share
    Amarin, HLS Present REDUCE-IT & EPA Mechanistic Data at Congress
    Amarin, HLS Present REDUCE-IT & EPA Mechanistic Data at Congress

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166085/18362/en/Amarin-and-HLS-Therapeutics-Collaborate-on-Presenting-REDUCE-IT-and-EPA-Mechanistic-Data-at-the-Canadian-Cardiovascular-Congress.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Saladax, HLS Strengthen Partnership With Distribution Agreement for Canada
    Saladax, HLS Strengthen Partnership With Distribution Agreement for Canada

    18 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211118006164/en

    BUSINESSWIRE
    18 Nov 2021
    Share Share
    HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa
    HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa

    16 Aug 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/hls-therapeutics-announces-promotional-agreement-with-pfizer-for-vascepa-r-in-canada-861060988.html

    NEWSWIRE
    16 Aug 2021
    Share Share
    HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results
    HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results

    05 Aug 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/hls-therapeutics-announces-second-quarter-fiscal-2021-financial-results-832582948.html

    NEWSWIRE
    05 Aug 2021
    Share Share
    HLS Therapeutics Comments on Rule Enacted by Quebec Health Minister
    HLS Therapeutics Comments on Rule Enacted by Quebec Health Minister

    01 Apr 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/hls-therapeutics-comments-on-rule-enacted-by-quebec-health-minister-christian-dube-and-the-absence-of-an-exception-for-new-refractory-schizophrenic-patients-897317540.html

    NEWSWIRE
    01 Apr 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search